Codiak BioSciences, Inc.
METHODS OF TREATING TUBERCULOSIS

Last updated:

Abstract:

The present disclosure relates to extracellular vesicles, e.g., exosomes, comprising a cytokine, e.g., Interleukin-12 (IL-12), and, optionally, a TB antigen. Also provided herein are methods of inducing an immune response against Mycobacterium tuberculosis in a subject in need thereof comprising administering an extracellular vesicle comprising a cytokine, e.g., IL-12, and, optionally, a TB antigen.

Status:
Application
Type:

Utility

Filling date:

17 Apr 2020

Issue date:

14 Jul 2022